BioMarin Pharmaceutical | Bienes

2022Q32023Q32024Q3

	Assets	Cambio		Fecha
Acadia Pharmaceuticals	USD 1.19B		210.89M	2024-12
Agios Pharmaceuticals	USD 1.66B		128.6M	2024-12
Alnylam Pharmaceuticals	USD 4.24B		34.94M	2024-12
Amgen	USD 91.84B		956M	2024-12
Bayer	EUR 110.85B		3.9B	2024-12
Biogen	USD 28.05B		263.9M	2024-12
BioMarin Pharmaceutical	USD 6.99B		137.74M	2024-12
Gilead Sciences	USD 59B		4.47B	2024-12
Incyte	USD 5.44B		431.89M	2024-12
Insmed	USD 2.03B		27.74M	2024-12
Ionis Pharmaceuticals	USD 3B		77.42M	2024-12
Moderna	USD 14.14B		1.66B	2024-12
Neurocrine Biosciences	USD 3.72B		183.7M	2024-12
PTC Therapeutics	USD 1.71B		137.21M	2024-12
Regeneron Pharmaceuticals	USD 37.76B		317.5M	2024-12
Roche Holding	CHF 101.8B		6.02B	2024-12
Sanofi	129.76B		3.29B	2024-06
Sarepta Therapeutics	USD 3.96B		363.24M	2024-12
Ultragenyx Pharmaceutical	USD 1.5B		34.91M	2024-12
United Therapeutics	USD 7.36B		240.9M	2024-12
Vertex Pharmaceuticals	USD 22.53B		293M	2024-12

BioMarin Pharmaceutical Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.